Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma.
- DOI
- 10.1016/j.dib.2016.08.039
- Published
- 2016 Dec
- Container
- Data in brief
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.dib.2016.08.039,
title = {Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma.},
author = {Erpenbeck VJ and Popov TA and Miller D and Weinstein SF and Spector S and Magnusson B and Osuntokun W and Goldsmith P and Weiss M and Beier J},
year = {2016},
journal = {Data in brief},
doi = {10.1016/j.dib.2016.08.039},
url = {https://doi.org/10.1016/j.dib.2016.08.039}
}RIS
TY - JOUR TI - Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma. AU - Erpenbeck VJ AU - Popov TA AU - Miller D AU - Weinstein SF AU - Spector S AU - Magnusson B AU - Osuntokun W AU - Goldsmith P AU - Weiss M AU - Beier J PY - 2016 JO - Data in brief DO - 10.1016/j.dib.2016.08.039 UR - https://doi.org/10.1016/j.dib.2016.08.039 ER -
APA
VJ, E., TA, P., D, M., SF, W., S, S., B, M., W, O., P, G., M, W., & J, B. (2016). Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma.. Data in brief. https://doi.org/10.1016/j.dib.2016.08.039
Source records
- pubmed · retrieved 2026-09-26T20:29:08.340Z